Maxcyte (MXCT) Non Operating Income (2020 - 2026)

Maxcyte (MXCT) has 7 years of Non Operating Income data on file, last reported at $1.4 million in Q1 2026.

• Non Operating Income for Q1 2026 came in at $1.4 million, down 29.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 million (down 29.27% YoY), and the FY2025 annual result was $7.3 million, down 28.35% from the prior year.
• Non Operating Income fell to $1.4 million in Q1 2026 per MXCT's latest filing, from $1.6 million in the prior quarter.
• Over five years, Non Operating Income peaked at $2.8 million in Q4 2023 and troughed at $91800.0 in Q1 2022.
• A 5-year average of $1.9 million and a median of $2.0 million in 2025 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2022 and 2025: Non Operating Income soared 10506.52% in 2022, then sank 30.57% in 2025.
• A 5-year view of Non Operating Income shows it stood at $1.9 million in 2022, then surged by 45.18% to $2.8 million in 2023, then declined by 18.24% to $2.3 million in 2024, then slipped by 29.25% to $1.6 million in 2025, then fell by 11.96% to $1.4 million in 2026.
• Business Quant data shows MXCT's Non Operating Income at $1.4 million in Q1 2026, $1.6 million in Q4 2025, and $1.7 million in Q3 2025.